The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations

Keyphrases

• Therapeutic Target 100%
• Head-and-neck Cancer 100%
• Head-and-neck Squamous Cell Carcinoma (HNSCC) 100%
• STAT3 Signaling Pathway 100%
• Phosphorylation 33%
• STAT3 Signaling 33%
• Epidermal Growth Factor Receptor 33%
• Targeted Agents 33%
• Growth Factors 33%
• Tumor Progression 33%
• Transcriptional Repressor 33%
• Signal Transducer 33%
• Protein Tyrosine Phosphatase 1B (PTP1B) 33%
• Treatment Resistance 33%
• Tumor Suppressor 33%
• Oncogene 33%
• Hyperactivity 33%
• Cellular Response 33%
• Growth Hormone Receptor 33%
• Tumor Formation 33%
• Gain-of-function mutation 33%
• Cytokine Factors 33%
• Clinical Development 33%
• Dephosphorylate 33%
• Immune Escape 33%
• Janus Kinase 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Head and Neck Cancer 100%
• Head and Neck Squamous Cell Carcinoma 100%
• Malignant Neoplasm 33%
• Cytokine 33%
• Epidermal Growth Factor Receptor 33%
• Carcinogenesis 33%
• Tumor Growth 33%
• Growth Factor 33%
• Tumor Suppressor Protein 33%
• Janus Kinase 33%
• Growth Factor Receptor 33%
• Protein Tyrosine Phosphatase 33%